Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Clinical trials exploring intravenous immunoglobulin and Janus kinase inhibition headline a robust ...
The new Scoring system for Cancer Risk in idiopathic Inflammatory Myositis (SCRIM), which incorporated age, sex, smoking status, dermatomyositis, anti‑transcriptional intermediary factor 1‑gamma (anti ...
Malignancies may initially present with muscle weakness and elevated muscle enzymes. Age and gender-specific cancer screening should be completed or updated in those with a myopathic process. 9,10 ...
Idiopathic inflammatory myopathies (IIM) represent a heterogeneous group of autoimmune disorders primarily characterised by progressive muscle weakness and inflammation, but with potential involvement ...
Despite modern medical therapies, multiorgan idiopathic inflammatory myopathies (IIM) are associated with reduced quality of life and life expectancy. A systematic review of all published ...
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for ...
Patient enrollment for idiopathic inflammatory myopathy and stiff person syndrome cohort expected to be initiated in the first quarter of 2025 Company plans to report initial clinical data from Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results